Alemtuzumab for the treatment of multiple sclerosis. (2015)

First Author: Willis MD
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/tcrm.s80112

PubMed Identifier: 25848299

Publication URI: http://europepmc.org/abstract/MED/25848299

Type: Journal Article/Review

Volume: 11

Parent Publication: Therapeutics and clinical risk management

ISSN: 1176-6336